Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex

BMC Cardiovascular Disorders

Volumn 12, Issue , 2012, Pages

  Gomez Marcos, Manuel A ^a   Recio Rodríguez, Jose I ^a   Patino Alonso, Maria C ^a   Agudo Conde, Cristina ^a   Gomez Sanchez, Leticia ^a   Rodriguez Sanchez, Emiliano ^a   Gomez Sanchez, Marta ^a   Martinez Vizcaino, Vicente ^b   Garcia Ortiz, Luis ^a  

^a Biomedical Research Institute of Salamanca IBSAL   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Arterial stiffness; High sensitive C reactive protein; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN;

ADULT; AGED; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; AUGMENTATION INDEX; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE PRESSURE; PULSE WAVE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; C-REACTIVE PROTEIN; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PREDICTIVE VALUE OF TESTS; PULSE WAVE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; VASCULAR STIFFNESS;

EID: 84861852792     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-12-37     Document Type: Article

References (38)

1. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999, 99(2):237-242. 10.1161/01.CIR.99.2.237, 9892589.
2. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347(20):1557-1565. 10.1056/NEJMoa021993, 12432042.
3. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107(3):363-369. 10.1161/01.CIR.0000053730.47739.3C, 12551853.
4. Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol 2007, 49(21):2129-2138. 10.1016/j.jacc.2007.02.052, 17531663.
5. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375(9709):132-140. 3162187, 20031199.
6. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350(14):1387-1397. 10.1056/NEJMoa032804, 15070788.
7. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB. C-reactive protein and coronary heart disease: a critical review. J Intern Med 2008, 264(4):295-314. 10.1111/j.1365-2796.2008.02015.x, 18823504.
8. Rizzo M, Corrado E, Coppola G, Muratori I, Mezzani A, Novo G, Novo S. The predictive role of C-reactive protein in patients with hypertension and subclinical atherosclerosis. Intern Med J 2009, 39(8):539-545. 10.1111/j.1445-5994.2009.01955.x, 19323703.
9. Kampus P, Kals J, Ristimae T, Fischer K, Zilmer M, Teesalu R. High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons. J Hypertens 2004, 22(6):1133-1139. 10.1097/00004872-200406000-00014, 15167448.
10. Schumacher W, Cockcroft J, Timpson NJ, McEniery CM, Gallacher J, Rumley A, Lowe G, Smith GD, Wilkinson IB, Ben-Shlomo Y. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009, 53(2):150-157.
11. Janner JH, Godtfredsen NS, Ladelund S, Vestbo J, Prescott E. The association between aortic augmentation index and cardiovascular risk factors in a large unselected population. J Hum Hypertens 2011,
12. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A, Gallacher J, Ben-Shlomo Y, Cockcroft JR, Wilkinson IB. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly prospective study. Hypertension 2010, 56(1):36-43. 10.1161/HYPERTENSIONAHA.110.150896, 20530296.
13. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB. Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 2011, 365(3):213-221. 10.1056/NEJMoa1012592, 3153949, 21774709.
14. Suh M, Lee JY, Ahn SV, Kim HC, Suh I. C-reactive protein and carotid intima-media thickness in a population of middle-aged Koreans. J Prev Med Public Health 2009, 42(1):29-34. 10.3961/jpmph.2009.42.1.29, 19229122.
15. World Medical Association declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. Jama 1997, 277(11):925-926. World Medical Association declaration of Helsinki.
16. Garcia-Ortiz L, Ramos-Delgado E, Recio-Rodriguez JI, Agudo-Conde C, Martinez-Salgado C, Patino-Alonso MC, Rodriguez-Sanchez E, Gomez-Marcos MA, . Group FV Peripheral and central arterial pressure and its relationship to vascular target organ damage in carotid artery, retina and arterial stiffness. Development and validation of a tool. The Vaso risk study. BMC Publ Health 2011, 11(1):266. Group FV.
17. Montagne P, Laroche P, Cuilliere ML, Varcin P, Pau B, Duheille J. Microparticle-enhanced nephelometric immunoassay for human C-reactive protein. J Clin Lab Anal 1992, 6(1):24-29. 10.1002/jcla.1860060106, 1542080.
18. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Grassi G, Sega R. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007, 49(6):1265-1270. 10.1161/HYPERTENSIONAHA.107.088708, 17452502.
19. Coca A, Bertomeu V, Dalfo A, Esmatjes E, Guillen F, Guerrero L, Llisterri JL, Marin-Iranzo R, Megia C, Rodriguez-Manas L, et al. Blood pressure self measurement: Spanish consensus document. Nefrologia 2007, 27(2):139-153.
20. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O'Malley K, Jamieson M, Altman D, Bland M, Atkins N. The British Hypertension Society protocol for the evaluation of automated and semi-automated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990, 8(7):607-619. 10.1097/00004872-199007000-00004, 2168451.
21. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23(1):75-80. 10.1159/000097034, 17108679.
22. Gavish B, Ben-Dov IZ, Bursztyn M. Linear relationship between systolic and diastolic blood pressure monitored over 24 h: assessment and correlates. J Hypertens 2008, 26(2):199-209. 10.1097/HJH.0b013e3282f25b5a, 18192832.
23. Gavish B, Ben-Dov IZ, Kark JD, Mekler J, Bursztyn M. The association of a simple blood pressure-independent parameter derived from ambulatory blood pressure variability with short- mortality. Hypertens Res 2009, 32(6):488-495. 10.1038/hr.2009.39, 19390534.
24. Stergiou GS, Kollias A, Rarra VC, Roussias LG. Ambulatory arterial stiffness index: reproducibility of different definitions. Am J Hypertens 2010, 23(2):129-134. 10.1038/ajh.2009.217, 19927133.
25. Van Trijp MJ, Uiterwaal CS, Bos WJ, Oren A, Grobbee DE, Bots ML. Noninvasive arterial measurements of vascular damage in healthy young adults: relation to coronary heart disease risk. Ann Epidemiol 2006, 16(2):71-77. 10.1016/j.annepidem.2005.09.005, 16305824.
26. Sander K, Horn CS, Briesenick C, Sander D. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study. Stroke 2007, 38(11):2881-2886. 10.1161/STROKEAHA.106.481531, 17885262.
27. Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005, 36(10):2138-2142. 10.1161/01.STR.0000181740.74005.ee, 16151032.
28. Ruixing Y, Limei Y, Yuming C, Dezhai Y, Weixiong L, Muyan L, Fengping H, Jinzhen W, Guangqing Y, Zhenbiao N. Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res 2006, 29(6):423-432. 10.1291/hypres.29.423, 16940705.
29. Takahashi W, Ohnuki T, Honma K, Kawada S, Takagi S. The significance of multiple risk factors for early carotid atherosclerosis in Japanese subjects. Intern Med 2007, 46(20):1679-1684. 10.2169/internalmedicine.46.0240, 17938520.
30. Okazaki S, Furukado S, Abe Y, Tanaka M, Miwa K, Yamagami H, Sakaguchi M, Sakoda S, Kitagawa K. Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients. Cerebrovasc Dis 2010, 30(2):180-187. 10.1159/000317106, 20588013.
31. Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004, 35(7):1625-1630. 10.1161/01.STR.0000130422.89335.81, 15155971.
32. Amer MS, Elawam AE, Khater MS, Omar OH, Mabrouk RA, Taha HM. Association of high-sensitivity C-reactive protein with carotid artery intima-media thickness in hypertensive older adults. J Am Soc Hypertens 2011, 5(5):395-400. 10.1016/j.jash.2011.03.004, 21524639.
33. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S. Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res 2006, 37(8):1004-1009. 10.1016/j.arcmed.2006.06.005, 17045118.
34. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J 2004, 68(4):297-303. 10.1253/circj.68.297, 15056824.
35. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605. 10.1093/eurheartj/ehl254, 17000623.
36. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation 1997, 95(7):1827-1836. 10.1161/01.CIR.95.7.1827, 9107170.
37. Segers P, Mahieu D, Kips J, Van Bortel LM. The use of a generalized transfer function: different processing, different results!. J Hypertens 2007, 25(9):1783-1787. 10.1097/HJH.0b013e3282ef5c5f, 17762638.
38. Hope SA, Meredith IT, Cameron JD. Arterial transfer functions and the reconstruction of central aortic waveforms: myths, controversies and misconceptions. J Hypertens 2008, 26(1):4-7. 10.1097/HJH.0b013e3282f0c9f5, 18090531.